News

Please click here to see the latest news stories relating to Covid-19
 
 

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your orgnaisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Unlike some challenges which are contained within regions, states or continents, the pandemic has sent shockwaves across the entire globe. As a result, all international supply chains have f...

The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have announced the launch of an innovative COVID-19 drug testing platform, AGILE.

Newcastle City Council will provide much-needed business support for SMEs impacted by COVID-19.

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces the launch of its Clarigene™ SARS-CoV-2 test for research use only (‘RUO’). The Clarigene™ SAR...

Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has received CE-IVD marking for its Illumina-based IONA® test, the Company’s flagship non-inva...

Read Peak Proteins' June Newsletter - Inside Peak...

Researchers at the University of Liverpool have led the first nationwide surveillance study of the neurological complications of COVID-19.

As part of the agreement, Biocair will transport selected blood samples to specialist laboratories for investigation to find out if the individual has developed antibodies against the SARS-C...

In this issue we welcome new International Head of IT Law -Jagvinder Singh Kang as well as an article about moving out of lockdown- guidance for research facilities, a look at data privacy/ ...

Onyx Health are launching a new Interactive Learning Environment (ILE) to revolutionise healthcare communication

An article about how some pharmaceutical and biotech companies are using patent bundling to accelerate important R&D activity during the pandemic.

Ethypharm have collaborated with RSSL to accelerate the manufacture of fentanyl injection, a critical medicine for the treatment of COVID-19

Sign up to our Newsletter

Our Valued Sponsors & Partners